Alkermes plc Cash Flow Statement
ALKS / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Alkermes plc generated $521M in operating cash flow and $480M in free cash flow in FY2025. Free cash flow margin was 32.5% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Strong profit margin: 22.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $241.7M | $367.1M | $355.8M | -$158.3M | -$48.2M | -$110.9M | -$196.6M | -$139.3M | -$157.9M | -$208.4M | $17.6M | -$30.1M | $17.6M | $25.0M | -$45.5M |
| Depreciation & Amortization | $27.2M | $28.5M | $74.9M | $77.9M | $78.7M | $81.9M | $80.4M | $103.7M | $98.5M | $94.3M | $70.8M | $98.1M | $70.8M | $73.8M | $8.7M |
| Operating Cash Flow | $520.8M | $439.1M | $401.4M | $21.0M | $101.7M | $82.8M | $72.1M | $99.3M | $19.2M | -$63.8M | $147.5M | $11.1M | $147.5M | $71.2M | -$2.5M |
| Capital Expenditures | $40.4M | $33.5M | $48.0M | $38.3M | $28.0M | $42.2M | $90.9M | $69.4M | $51.3M | $43.7M | $19.1M | $33.7M | $19.1M | $22.2M | $9.4M |
| Free Cash Flow | $480.3M | $405.6M | $353.3M | -$17.2M | $73.7M | $40.6M | -$18.9M | $29.9M | -$32.1M | -$107.5M | $128.5M | -$22.5M | $128.5M | $49.0M | -$11.9M |
| Share Buybacks | - | $200.3M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Margin | 32.6% | 26.0% | 21.2% | -1.6% | 6.3% | 3.9% | -1.6% | 2.7% | -3.5% | -14.4% | 21.5% | -3.6% | 21.5% | 11.9% | -6.4% |